A Study of Major and Minor Complications of 1500 Transvenous Lead Extraction Procedures Performed with Optimal Safety at Two High-Volume Referral Centers

Łukasz Tułecki, Anna Polewczyk, Wojciech Jacheć, Dorota Nowosielecka, Konrad Tomków, Paweł Stefańczyk, Jarosław Kosior, Krzysztof Duda, Maciej Polewczyk, Andrzej Kutarski, Łukasz Tułecki, Anna Polewczyk, Wojciech Jacheć, Dorota Nowosielecka, Konrad Tomków, Paweł Stefańczyk, Jarosław Kosior, Krzysztof Duda, Maciej Polewczyk, Andrzej Kutarski

Abstract

Background: Transvenous lead extraction (TLE) is the preferred management strategy for complications related to cardiac implantable electronic devices. TLE sometimes can cause serious complications. Methods: Outcomes of TLE procedures using non-powered mechanical sheaths were analyzed in 1500 patients (mean age 68.11 years; 39.86% females) admitted to two high-volume centers. Results: Complete procedural success was achieved in 96.13% of patients; clinical success in 98.93%, no periprocedural death occurred. Mean lead dwell time in the study population was 112.1 months. Minor complications developed in 115 (7.65%), major complications in 33 (2.20%) patients. The most frequent minor complications were tricuspid valve damage (TVD) (3.20%) and pericardial effusion that did not necessitate immediate intervention (1.33%). The most common major complication was cardiac laceration/vascular tear (1.40%) followed by an increase in TVD by two or three grades to grade 4 (0.80%). Conclusions: Despite the long implant duration (112.1 months) satisfying results without procedure-related death can be obtained using mechanical tools. Lead remnants or severe tricuspid regurgitation was the principal cause of lack of clinical and procedural success. Worsening TR(Tricuspid regurgitation) (due to its long-term consequences), but not cardiac/vascular wall damage; is still the biggest TLE-related problem; when non-powered mechanical sheaths are used as first-line tools.

Keywords: cardiac laceration/vascular tear; epicardial fluid; minor and major complications; transvenous lead extraction; tricuspid valve damage.

Conflict of interest statement

Authors declare no conflict of interest.

References

    1. Love C.J., Wilkoff B.L., Byrd C.L., Belott P.H., Brinker J.A., Fearnot N.E., Friedman R.A., Furman S., Goode L.B., Hayes D.L., et al. Recommendations for extraction of chronically implanted transvenous pacing and defibrillator leads: Indications, facilities, training. North American Society of Pacing and Electrophysiology Lead Extraction Conference Faculty. Pacing Clin Electrophysiol. 2000;23:544–551.
    1. Wilkoff B.L., Love C.J., Byrd C.L., Bongiorni M.G., Carrillo R.G., Crossley G.H., Epstein L.M., Friedman R.A., Heart Rhythm Society. American Heart Association et al. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: This document was endorsed by the American Heart Association (AHA) Heart Rhythm. 2009;6:1085–1104. doi: 10.1016/j.hrthm.2009.05.020.
    1. Deharo J.C., Bongiorni M.G., Rozkovec A., Bracke F., Defaye P., Fernandez-Lozano I., Golzio P.G., Hansky B., Kennergren C., Manolis A.S., et al. Pathways for training and accreditation for transvenous lead extraction: A European Heart Rhythm Association position paper. Europace. 2012;14:124–134.
    1. Kusumoto F.M., Schoenfeld M.H., Wilkoff B., Berul C.I., Birgersdotter-Green U.M., Carrillo R., Cha Y.M., Clancy J., Deharo J.C., Ellenbogen K.A., et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14:e503–e551. doi: 10.1016/j.hrthm.2017.09.001.
    1. Bongiorni M.G., Burri H., Deharo J.C., Starck C., Kennergren C., Saghy L., Rao A., Tascini C., Lever N., Kutarski A., et al. 2018 EHRA expert consensus statement on lead extraction: Recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: Endorsed by APHRS/HRS/LAHRS. Europace. 2018;20:1217. doi: 10.1093/europace/euy050.
    1. Kołodzińska A., Kutarski A., Koperski Ł., Grabowski M., Małecka B., Opolski G. Differences in encapsulating lead tissue in patients who underwent transvenous lead removal. Europace. 2012;14:994–1001. doi: 10.1093/europace/eur384.
    1. Nowosielecka D., Polewczyk A., Jacheć W., Tułecki Ł., Kleinrok A., Kutarski A. Echocardiographic findings in patients with cardiac implantable electronic devices-analysis of factors predisposing to lead-associated changes. Clin. Physiol. Funct. Imaging. 2021;41:25–41. doi: 10.1111/cpf.12662.
    1. Brunner M.P., Cronin E.M., Wazni O., Baranowski B., Saliba W.I., Sabik J.F., Lindsay B.D., Wilkoff B.L., Tarakji K.G. Outcomes of patients requiring emergent surgical or endovascular intervention for catastrophic complications during transvenous lead extraction. Heart Rhythm. 2014;11:419–425. doi: 10.1016/j.hrthm.2013.12.004.
    1. Wang W., Wang X., Modry D., Wang S. Cardiopulmonary bypass standby avoids fatality due to vascular laceration in laser-assisted lead extraction. J. Card. Surg. 2014;29:274–278. doi: 10.1111/jocs.12294.
    1. Bashir J., Fedoruk L.M., Ofiesh J., Karim S.S., Tyers G.F.O. Classification and Surgical Repair of Injuries Sustained During Transvenous Lead Extraction’. Circ. Arrhythm. Electrophysiol. 2016;9:e003741.
    1. Maus T.M., Shurter J., Nguyen L., Birgersdotter-Green U., Pretorius V. Multidisciplinary approach to transvenous lead extraction: A single center’s experience. J. Cardiothorac. Vasc. Anesth. 2015;29:265–270. doi: 10.1053/j.jvca.2014.11.010.
    1. Caniglia-Miller J.M., Bussey W.D., Kamtz N.M., Tsai S.F., Erickson C.C., Anderson D.R., Moulton M.J. Surgical management of major intrathoracic hemorrhage resulting from high-risk transvenous pacemaker/defibrillator lead extraction. J. Card Surg. 2015;30:149–153. doi: 10.1111/jocs.12500.
    1. Hosseini S.M., Rozen G., Kaadan M.I., Galvin J., Ruskin J.N. Safety and In-Hospital Outcomes of Transvenous Lead Extraction for Cardiac Implantable Device-Related Infections: Analysis of 13 Years of Inpatient Data in the United States. JACC Clin. Electrophysiol. 2019;5:1450–1458. doi: 10.1016/j.jacep.2019.08.020.
    1. Hauser R.G., Katsiyiannis W.T., Gornick C.C., Almquist A.K., Kallinen L.M. Deaths and cardiovascular injuries due to device-assisted implantable cardioverter–defibrillator and pacemaker lead extraction. Europace. 2010;1:395–401. doi: 10.1093/europace/eup375.
    1. Kutarski A., Czajkowski M., Pietura R., Obszanski B., Polewczyk A., Jachec W., Polewczyk M., Mlynarczyk K., Grabowski M., Opolski G. Effectiveness, safety, and long-term outcomes of non-powered mechanical sheaths for transvenous lead extraction. Europace. 2018;20:1324–1333. doi: 10.1093/europace/eux218.
    1. Issa Z.F. Transvenous lead extraction in 1000 patients guided by intraprocedural risk stratification without surgical backup. Heart Rhythm. 2021;18:1272–1278. doi: 10.1016/j.hrthm.2021.03.031. online ahead of print.
    1. Roberto M., Sicuso R., Manganiello S., Catto V., Salvi L., Nafi M., Casella M., Rossi F., Grillo F., Saccocci M., et al. Cardiac surgeon and electrophysiologist shoulder-to-shoulder approach: Hybrid room, a kingdom for two. A zero mortality transvenous lead extraction single center experience. Int. J. Cardiol. 2019;279:35–39. doi: 10.1016/j.ijcard.2018.12.074.
    1. Gaca J.G., Lima B., Milano C.A., Lin S.S., Davis R.D., Lowe J.E., Smith P.K. Laser-assisted extraction of pacemaker and defibrillator leads: The role of the cardiac surgeon. Ann. Thorac. Surg. 2009;87:1446–1450. doi: 10.1016/j.athoracsur.2009.02.015.
    1. Park S.J., Gentry J.L., 3rd, Varma N., Wazni O., Tarakji K.G., Mehta A., Mick S., Grimm R., Wilkoff B.L. Transvenous Extraction of Pacemaker and Defibrillator Leads and the Risk of Tricuspid Valve Regurgitation. JACC Clin. Electrophysiol. 2018;4:1421–1428. doi: 10.1016/j.jacep.2018.07.011.
    1. Pecha S., Castro L., Gosau N., Linder M., Vogler J., Willems S., Reichenspurner H., Hakmi S. Evaluation of tricuspid valve regurgitation following laser lead extraction. Eur. J. Cardiothorac. Surg. 2017;51:1108–1111. doi: 10.1093/ejcts/ezx011.
    1. Givon A., Vedernikova N., Luria D., Vatury O., Kuperstein R., Feinberg M.S., Eldar M., Glikson M., Nof E. Tricuspid Regurgitation following Lead Extraction: Risk Factors and Clinical Course. Isr. Med. Assoc. J. 2016;18:18–22.
    1. Regoli F., Caputo M., Conte G., Faletra F.F., Moccetti T., Pasotti E., Cassina T., Casso G., Schlotterbeck H., Engeler A., et al. Clinical utility of routine use of continuous transesophageal echocardiography monitoring during transvenous lead extraction procedure. Heart Rhythm. 2015;12:313–320. doi: 10.1016/j.hrthm.2014.10.013.
    1. Coffey J.O., Sager S.J., Gangireddy S., Levine A., Viles-Gonzalez J.F., Fischer A. The impact of transvenous lead extraction on tricuspid valve function. Pacing Clin. Electrophysiol. 2014;37:19–24. doi: 10.1111/pace.12236.
    1. Rodriguez Y., Mesa J., Arguelles E., Carrillo R.G. Tricuspid insufficiency after laser lead extraction. Pacing Clin. Electrophysiol. 2013;36:939–944. doi: 10.1111/pace.12160.
    1. Franceschi F., Thuny F., Giorgi R., Sanaa I., Peyrouse E., Assouan X., Prévôt S., Bastard E., Habib G., Deharo J.C. Incidence, risk factors, and outcome of traumatic tricuspid regurgitation after percutaneous ventricular lead removal. J. Am. Coll. Cardiol. 2009;53:2168–2174. doi: 10.1016/j.jacc.2009.02.045.
    1. Jacheć W., Polewczyk A., Polewczyk M., Tomasik A., Kutarski A. Transvenous Lead Extraction SAFeTY Score for Risk Stratification and Proper Patient Selection for Removal Procedures Using Mechanical Tools. J. Clin. Med. 2020;9:361. doi: 10.3390/jcm9020361.
    1. Nowosielecka D., Jacheć W., Polewczyk A., Tułecki Ł., Tomków K., Stefańczyk P., Tomaszewski A., Brzozowski W., Szcześniak-Stańczyk D., Kleinrok A., et al. Transesophageal Echocardiography as a Monitoring Tool during Transvenous Lead Extraction-does It Improve Procedure Effectiveness? J. Clin. Med. 2020;9:1382. doi: 10.3390/jcm9051382.
    1. Nowosielecka D., Polewczyk A., Jacheć W., Tułecki Ł., Tomków K., Stefańczyk P., Kleinrok A., Kutarski A. A new approach to the continuous monitoring of transvenous lead extraction using transesophageal echocardiography-Analysis of 936 procedures. Echocardiography. 2020;37:601–611. doi: 10.1111/echo.14628.
    1. Nowosielecka D., Polewczyk A., Jacheć W., Kleinrok A., Tułecki Ł., Kutarski A. Transesophageal echocardiography for the monitoring of transvenous lead extraction. Kardiol. Pol. 2020;78:1206–1214. doi: 10.33963/KP.15651.
    1. Nowosielecka D., Jacheć W., Polewczyk A., Kleinrok A., Tułecki Ł., Kutarski A. The prognostic value of transesophageal echocardiography after transvenous lead extraction: Landscape after battle. Cardiovasc. Diagn. Ther. 2021;11:394–410. doi: 10.21037/cdt-20-871.
    1. Mehrotra D., Kejriwal N.K. Tricuspid valve repair for torrential tricuspid regurgitation after permanent pacemaker lead extraction. Tex. Heart Inst. J. 2011;38:305–307.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren